sequencing parp inhibitors in advanced ovarian cancer
Published 5 years ago • 182 plays • Length 6:43Download video MP4
Download video MP3
Similar videos
-
3:23
sequencing antiangiogenic agents in advanced ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
1:22
dr. penson on the eligibility criteria for parp inhibitors in advanced ovarian cancer
-
8:15
sequencing therapies in ovarian cancer
-
0:58
dr. o’malley on the optimal use of parp inhibitors in advanced ovarian cancer
-
5:34
differences among parp inhibitors in ovarian cancer
-
59:14
parp inhibitors in ovarian cancer: clinical updates from sgo 2023
-
57:11
personalizing advanced ovarian cancer treatment with parp inhibitors and novel approaches
-
6:44
parp inhibitors in advanced ovarian cancer
-
1:25
dr. konecny on the indications for parp inhibitors in recurrent ovarian cancer
-
9:39
parp inhibitor selection in ovarian cancer
-
4:40
solo-1 and parp inhibitors in ovarian cancer
-
5:53
adverse-effect profiles of parp inhibitors in ovarian cancer
-
3:44
the future role of parp inhibition in ovarian cancer
-
6:51
platinum sensitivity and parp inhibition in ovarian cancer
-
1:47
dr. liu on parp inhibitors in recurrent ovarian cancer
-
0:46
parp inhibitor rechallenging in ovarian cancer
-
3:58
dana chase, md, considers the role of parp inhibitors in advanced ovarian cancer today
-
0:50
dr. secord on the role of parp inhibitors in ovarian cancer